Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells

Molecular and Cellular Endocrinology

Volumn 314, Issue 1, 2010, Pages 136-142

  Feliers, Denis ^a   Kasinath, Balakuntalam S ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Epithelial cells; Glucose; Kidney; Renin angiotensin system; VEGF

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RENIN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DATA ANALYSIS; ENZYME ACTIVATION; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HORMONE SYNTHESIS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOSE; KIDNEY TUBULES, PROXIMAL; MICE; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN; RENIN-ANGIOTENSIN SYSTEM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70350211835     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.09.009     Document Type: Article

References (69)

1. Ahn S., Wei H., Garrison T.R., and Lefkowitz R.J. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2. J. Biol. Chem. 279 (2004) 7807-7811
2. Baker K.M., Chernin M.I., Schreiber T., Sanghi S., Haiderzaidi S., Booz G.W., Dostal D.E., and Kumar R. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul. Pept. 120 (2004) 5-13
3. Berry C., Touyz R., Dominiczak A.F., Webb R.C., and Johns D.G. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H2337-H2365
4. Booz G.W., Conrad K.M., Hess A.L., Singer H.A., and Baker K.M. Angiotensin-II-binding sites on hepatocyte nuclei. Endocrinology 130 (1992) 3641-3649
5. Burns K.D. Angiotensin II and its receptors in the diabetic kidney. Am. J. Kidney Dis. 36 (2000) 449-467
6. Burns K.D., Homma T., and Harris R.C. The intrarenal renin-angiotensin system. Semin. Nephrol. 13 (1993) 13-30
7. Campbell D.J. Circulating and tissue angiotensin systems. J. Clin. Invest. 79 (1987) 1-6
8. Carey R.M., and Siragy H.M. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol. Metab. 14 (2003) 274-281
9. Cha D.R., Kim N.H., Yoon J.W., J.O S.K., Cho W.Y., Kim H.K., and Won N.H. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int. Suppl. 77 (2000) S104-S112
10. De Vito E., Martinez D.E., Melian E.R., and Guardia D.C. Activation of renal renin by a protein plasma fraction: a novel enzymatic mechanism. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 113 (1996) 433-438
11. De Vriese A.S., Tilton R.G., Stephan C.C., and Lameire N.H. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J. Am. Soc. Nephrol. 12 (2001) 1734-1741
12. Duff J.L., Marrero M.B., Paxton W.G., Schieffer B., Bernstein K.E., and Berk B.C. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovasc. Res. 30 (1995) 511-517
13. Durvasula R.V., and Shankland S.J. Activation of a local renin angiotensin system in podocytes by glucose. Am. J. Physiol. Renal Physiol. 294 (2008) F830-F839
14. Feliers D., Duraisamy S., Barnes J.L., Ghosh-Choudhury G., and Kasinath B.S. Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am. J. Physiol. Renal Physiol. 288 (2005) F521-F529
15. Feliers D., Lee M.J., Ghosh-Choudhury G., Bomsztyk K., and Kasinath B.S. Heterogeneous nuclear ribonucleoprotein K contributes to angiotensin II stimulation of vascular endothelial growth factor mRNA translation. Am. J. Physiol. Renal Physiol. 293 (2007) F607-F615
16. Flyvbjerg A., Dagnaes-Hansen F., De Vriese A.S., Schrijvers B.F., Tilton R.G., and Rasch R. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51 (2002) 3090-3094
17. Freeman R.H., and Rostorfer H.H. Hepatic changes in renin substrate biosynthesis and alkaline phosphatase activity in the rat. Am. J. Physiol. 223 (1972) 364-370
18. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., and Semenza G.L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277 (2002) 38205-38211
19. Gupta A., Decaillot F.M., Gomes I., Tkalych O., Heimann A.S., Ferro E.S., and Devi L.A. Conformation state-sensitive antibodies to G-protein-coupled receptors. J. Biol. Chem. 282 (2007) 5116-5124
20. Haverty T.P., Kelly C.J., Hines W.H., Amenta P.S., Watanabe M., Harper R.A., Kefalides N.A., and Neilson E.G. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J. Cell Biol. 107 (1988) 1359-1368
21. Hsueh W.A. Potential effects of renin activation on the regulation of renin production. Am. J. Physiol. 247 (1984) F205-F212
22. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., Nishiyama A., Inagami T., and Hayashi M. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47 (2006) 894-900
23. Ingelfinger J.R., Zuo W.M., Fon E.A., Ellison K.E., and Dzau V.J. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J. Clin. Invest. 85 (1990) 417-423
24. Kagami S., Border W.A., Miller D.E., and Noble N.A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93 (1994) 2431-2437
25. Kennefick T.M., and Anderson S. Role of angiotensin II in diabetic nephropathy. Semin. Nephrol. 17 (1997) 441-447
26. Kim N.H., Oh J.H., Seo J.A., Lee K.W., Kim S.G., Choi K.M., Baik S.H., Choi D.S., Kang Y.S., Han S.Y., Han K.H., Ji Y.H., and Cha D.R. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int. 67 (2005) 167-177
27. Kohzuki M., Yasujima M., Kanazawa M., Yoshida K., Fu L.P., Obara K., Saito T., and Abe K. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. J. Hypertens. 13 (1995) 97-103
28. Kramer H.J., Glanzer K., Meyer-Lehnert H., Mohaupt M., and Predel H.G. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones. J. Cardiovasc. Pharmacol. 15 6 Suppl. (1990) S91-S98
29. Kumar R., Singh V.P., and Baker K.M. The intracellular renin-angiotensin system: implications in cardiovascular remodeling. Curr. Opin. Nephrol. Hypertens. 17 (2008) 168-173
30. Lai K.N., Leung J.C., Lai K.B., To W.Y., Yeung V.T., and Lai F.M. Gene expression of the renin-angiotensin system in human kidney. J. Hypertens. 16 (1998) 91-102
31. Lansang M.C., Osei S.Y., Coletti C., Krupinski J., and Hollenberg N.K. Hyperglycaemia-induced intrarenal RAS activation: the contribution of metabolic pathways. J. Renin Angiotensin Aldosterone Syst. 3 (2002) 19-23
32. Lavrentyev E.N., Estes A.M., and Malik K.U. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ. Res. 101 (2007) 455-464
33. Lee E.Y., Shim M.S., Kim M.J., Hong S.Y., Shin Y.G., and Chung C.H. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes. Exp. Mol. Med. 36 (2004) 65-70
34. Lee H.J., Larue J.N., and Wilson I.B. Human plasma converting enzyme. Arch. Biochem. Biophys. 142 (1971) 548-551
35. Leehey D.J., Singh A.K., Alavi N., and Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int. Suppl. 77 (2000) S93-S98
36. Lewis E.J., Hunsicker L.G., Bain R.P., and Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 329 (1993) 1456-1462
37. Lindenmeyer M.T., Kretzler M., Boucherot A., Berra S., Yasuda Y., Henger A., Eichinger F., Gaiser S., Schmid H., Rastaldi M.P., Schrier R.W., Schlondorff D., and Cohen C.D. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J. Am. Soc. Nephrol. 18 (2007) 1765-1776
38. Mariappan M.M., Feliers D., Mummidi S., Choudhury G.G., and Kasinath B.S. High glucose, high insulin, and their combination rapidly induce laminin-β1 synthesis by regulation of mRNA translation in renal epithelial cells. Diabetes 56 (2007) 476-485
39. Mazzolai L., Nussberger J., Aubert J.F., Brunner D.B., Gabbiani G., Brunner H.R., and Pedrazzini T. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 31 (1998) 1324-1330
40. Mezzano S., Droguett A., Burgos M.E., Ardiles L.G., Flores C.A., Aros C.A., Caorsi I., Vio C.P., Ruiz-Ortega M., and Egido J. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int. Suppl. 86 (2003) S64-S70
41. Miyata N., Park F., Li X.F., and Cowley Jr. A.W. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am. J. Physiol. 277 (1999) F437-F446
42. Navar L.G., Inscho E.W., Majid S.A., Imig J.D., Harrison-Bernard L.M., and Mitchell K.D. Paracrine regulation of the renal microcirculation. Physiol. Rev. 76 (1996) 425-536
43. Nguyen G. Renin/prorenin receptors. Kidney Int. 69 (2006) 1503-1506
44. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., and Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109 (2002) 1417-1427
45. Ozono R., Wang Z.Q., Moore A.F., Inagami T., Siragy H.M., and Carey R.M. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30 (1997) 1238-1246
46. Pendergrass K.D., Averill D.B., Ferrario C.M., Diz D.I., and Chappell M.C. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2 Lewis rat. Am. J. Physiol. Renal Physiol. 290 (2006) F1497-F1506
47. Persson P.B. Renin: origin, secretion and synthesis. J. Physiol. 552 (2003) 667-671
48. Pupilli C., Lasagni L., Romagnani P., Bellini F., Mannelli M., Misciglia N., Mavilia C., Vellei U., Villari D., and Serio M. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J. Am. Soc. Nephrol. 10 (1999) 245-255
49. Re R.N., Vizard D.L., Brown J., and Bryan S.E. Angiotensin II receptors in chromatin fragments generated by micrococcal nuclease. Biochem. Biophys. Res. Commun. 119 (1984) 220-227
50. Remuzzi G., and Bertani T. Pathophysiology of progressive nephropathies. N. Engl. J. Med. 339 (1998) 1448-1456
51. Rizkalla B., Forbes J.M., Cooper M.E., and Cao Z. Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors. J. Am. Soc. Nephrol. 14 (2003) 3061-3071
52. Robertson Jr. A.L., and Khairallah P.A. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science 172 (1971) 1138-1139
53. Rohrwasser A., Ishigami T., Gociman B., Lantelme P., Morgan T., Cheng T., Hillas E., Zhang S., Ward K., Bloch-Faure M., Meneton P., and Lalouel J.M. Renin and kallikrein in connecting tubule of mouse. Kidney Int. 64 (2003) 2155-2162
54. Salem Y., Shpungin S., Pasder O., Pomp O., Taler M., Malovani H., and Nir U. Fer kinase sustains the activation level of ERK1/2 and increases the production of VEGF in hypoxic cells. Cell Signal. 17 (2005) 341-353
55. Sataranatarajan K., Lee M.J., Mariappan M.M., and Feliers D. PKCδ regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K. Cell Signal. 20 (2008) 969-977
56. Sataranatarajan K., Mariappan M.M., Lee M.J., Feliers D., Choudhury G.G., Barnes J.L., and Kasinath B.S. Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin. Am. J. Pathol. 171 (2007) 1733-1742
57. Scherf H., Pietsch R., Landsberg G., Kramer H.J., and Dusing R. Converting enzyme inhibitor ramipril stimulates prostacyclin synthesis by isolated rat aorta: evidence for a kinin-dependent mechanism. Klin. Wochenschr. 64 (1986) 742-745
58. Sealey J.E., Overlack A., Laragh J.H., Stumpe K.O., and Atlas S.A. Effect of captopril and aprotinin on inactive renin. J. Clin. Endocrinol. Metab. 53 (1981) 626-630
59. Simon M., Grone H.J., Johren O., Kullmer J., Plate K.H., Risau W., and Fuchs E. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 268 (1995) F240-F250
60. Singh R., and Leehey D.J. Effect of ACE inhibitors on angiotensin II in rat mesangial cells cultured in high glucose. Biochem. Biophys. Res. Commun. 357 (2007) 1040-1045
61. Singh V.P., Le B., Bhat V.B., Baker K.M., and Kumar R. High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H939-H948
62. Soffer R.L., Reza R., and Caldwell P.R. Angiotensin-converting enzyme from rabbit pulmonary particles. Proc. Natl. Acad. Sci. U.S.A. 71 (1974) 1720-1724
63. Vidotti D.B., Casarini D.E., Cristovam P.C., Leite C.A., Schor N., and Boim M.A. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am. J. Physiol. Renal Physiol. 286 (2004) F1039-F1045
64. Williams B. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?. Miner. Electrolyte Metab. 24 (1998) 400-405
65. Wolf G., Mueller E., Stahl R.A., and Ziyadeh F.N. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J. Clin. Invest. 92 (1993) 1366-1372
66. Wolf G., and Neilson E.G. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am. J. Physiol. 259 (1990) F768-F777
67. Wolf G., and Ziyadeh F.N. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol. 106 (2007) p26-31
68. Yoo T.H., Li J.J., Kim J.J., Jung D.S., Kwak S.J., Ryu D.R., Choi H.Y., Kim J.S., Kim H.J., Han S.H., Lee J.E., Han D.S., and Kang S.W. Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int. 71 (2007) 1019-1027
69. Ziyadeh F.N., and Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr. Diab. Rev. 4 (2008) 39-45